Back to top
more

Elevance Health, Inc. (ELV)

(Real Time Quote from BATS)

$498.09 USD

498.09
782,074

-7.07 (-1.40%)

Updated Oct 3, 2024 03:55 PM ET

After-Market: $498.28 +0.19 (0.04%) 4:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (178 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

Integer Holdings (ITGR) Q3 Earnings Beat, 2022 View Lowered

Integer Holdings' (ITGR) third-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.

DaVita (DVA) Q3 Earnings Lag Estimates, 2022 EPS View Cut

DaVita's (DVA) Q3 performance gets a boost from strength in both its segments.

Baxter (BAX) Q3 Earnings Meet Estimates, Hilrom Adds $735 M

Baxter's (BAX) third-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.

LabCorp (LH) Misses Q3 Earnings Estimates, Updates Guidance

LabCorp's (LH) organic revenues decline significantly, mainly due to major decrease in COVID-19 PCR and antibody testing sales.

Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised

Merit Medical (MMSI), in the third quarter, benefits from revenue growth in both its segments and the majority of product categories within its Cardiovascular unit.

Integra's (IART) Q3 Earnings Top, Gross Margin Declines

Integra (IART) notices recovery in procedure volumes leading to solid growth across most of its product portfolio in Q3.

Align Technology (ALGN) Q3 Earnings Lag Estimates, Margins Drop

The volatility surrounding inflationary pressure, weaker consumer confidence and the lingering impacts of COVID-19 shutdowns continue to pose challenges for Align Technology (ALGN).

CONMED (CNMD) Down on In-Line Q3 Earnings & Lower 2022 View

CONMED's (CNMD) adjusted third-quarter earnings reflect strong segmental performance. Unfavorable currency movement hurt sales growth. Inflationary or supply chain challenges hurt gross margin.

The Zacks Analyst Blog Highlights The Home Depot, Elevance Health, BP, Gilead Sciences and ServiceNow

The Home Depot, Elevance Health, BP, Gilead Sciences and ServiceNow are part of the Zacks top Analyst Blog.

Elevance Health, Inc. (ELV) Hit a 52 Week High, Can the Run Continue?

Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here's How Much a $1000 Investment in Elevance Health Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

West Pharmaceutical (WST) Q3 Earnings Miss, FY22 View Revised

West Pharmaceutical's (WST) third-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance.

Mark Vickery headshot

Top Stock Reports for The Home Depot, Elevance Health & BP

Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Elevance Health Inc. (ELV) and BP p.l.c. (BP).

Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Down

Robust demand for Thermo Fisher's (TMO) laboratory products and biopharma services buoys optimism. However, lower Life Sciences Solutions segment revenues in the third quarter disappoint.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Ideas feature highlights: Elevance Health, McKesson and Humana

Elevance Health, McKesson and Humana are part of Zacks Investment Ideas article.

Centene (CNC) Q3 Earnings Top on Medicaid Arm, Revenues Rise Y/Y

Centene's (CNC) third-quarter results reflect solid membership growth within its Medicaid and Medicare businesses. Management currently expects adjusted EPS within $5.65-$5.75 for 2022.

Derek Lewis headshot

3 Top-Ranked Medical Stocks Lapping the S&P 500

All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.

HCA Healthcare (HCA) Q3 Earnings Beat, Revenues Decline Y/Y

HCA Healthcare's (HCA) third-quarter results reflect a slight dip in expenses but lower revenues resulting from the havoc wreaked by Hurricane Ian on its Florida facilities.

Here is Why Growth Investors Should Buy Elevance Health (ELV) Now

Elevance Health (ELV) could produce exceptional returns because of its solid growth attributes.

ELV or PGNY: Which Is the Better Value Stock Right Now?

ELV vs. PGNY: Which Stock Is the Better Value Option?

Company News for Oct 20, 2022

Companies in The News Are: TRV,ALLY,BMI,ELV

Elevance Health (ELV) Beats on Q3 Earnings, Ups '22 EPS View

Elevance Health (ELV) is witnessing rapid growth in medical enrollment and expects to keep doing so.

Elevance Health (ELV) Beats Q3 Earnings and Revenue Estimates

Elevance Health (ELV) delivered earnings and revenue surprises of 6.06% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Elevance Health (ELV) to Post Q3 Earnings: A Beat in the Cards?

Elevance Health's (ELV) third-quarter results are likely to reflect improved premiums and net investment income.